NOVEL GROWTH FACTOR RELEASED BY KIDNEY EPITHELIAL CELLS
NOVEL GROWTH FACTOR RELEASED BY KIDNEY EPITHELIAL CELLS
批准号:
3239575
负责人:
FREDERICK Gary TOBACK
金额:
$14.94万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-09-30 至 1995-03-31
关键词:
autocrine complementary DNA deficient growth media enzyme linked immunosorbent assay epithelium gene expression growth factor growth factor receptors high performance liquid chromatography immunologic assay /test in situ hybridization ion transport kidney cell laboratory rat messenger RNA molecular cloning northern blottings nucleic acid probes protein sequence protein structure function sodium tissue /cell culture
中文摘要
这个项目的目标是确定一个人的生理意义,
刺激肾上皮细胞生长的明显新的蛋白质
细胞
我们以前发现了一种蛋白质,当非转化的猴子
将肾上皮细胞(BSC-1系)暴露于
降低培养基中钠的浓度;它被称为
低钠生长因子(LSGF)。 这种蛋白质具有明显的分子
体重约6,500,刺激猴子和狗的肾脏生长
培养的上皮细胞,但不是成纤维细胞,
二硫苏糖醇,似乎不同于已知的类似的生长因子,
相对于生物活性和氨基酸组成的大小,和
存在于细胞外基质中,
培养基的钠浓度降低。 的氨基末端
LSGF蛋白被阻断。 通过反相(RP)纯化LSGF的方案
HPLC是在03资助年度开发的。
该修订的申请描述了一种新的生物活性同种型,
通过RP HPLC检测到的LSGF具有不同于
先前描述的蛋白质。 此外,还制备了兔抗
已经制备了识别ELISA的两种LSGF同种型的LSGF,
也中和了各自的促生长活性。 来定义
LSGF的结构及其发挥生理作用的机制
在体外和体内对肾细胞的影响,需要新的试剂
将用于实现以下具体目标:
1.对LSGF蛋白进行部分测序;
2.使用寡核苷酸探针或免疫筛选来克隆
编码该蛋白,并研究其在细胞中的表达调控
增长;
3.建立LSGF免疫分析方法,研究LSGF蛋白的生理功能;
4.确定LSGF是否改变肾上皮细胞中的营养和离子转运
细胞
实现这些目标可以定义这种自分泌生长因子的作用
在肾脏生理学和病理生理学中。 确定机制,
LSGF法案可能是我们实现长期目标的重要一步,
配制含有特定组分的治疗溶液,
可以加速肾脏再生的营养素和生长因子
伤后
英文摘要
The goal of this project is to define the physiological significance of an
apparently novel protein that stimulates growth of kidney epithelial
cells.
We previously identified a protein that appears when nontransformed monkey
renal epithelial cells (BSC-1 line) are exposed for 3-5 minutes to a
reduced concentration of sodium in the culture medium; it is called the
low sodium growth factor (LSGF). This protein has an apparent molecular
weight about 6,500, stimulates growth of both monkey and canine kidney
epithelial cells in culture but not fibroblasts, resists denaturation by
dithiothreitol, appears to differ from known growth factors of similar
size with respect to biological activity and amino acid composition, and
resides in the extracellular matrix from which it is released when the
sodium concentration of the medium is reduced. The amino terminus of the
LSGF protein is blocked. A protocol to purify LSGF by reversed-phase (RP)
HPLC was developed during the 03 grant year.
This revised application describes a new biologically active isoform of
LSGF detected by RP HPLC that has a different amino acid composition than
the previously described protein. In addition, a rabbit antiserum against
LSGF has been prepared that recognizes both LSGF isoforms of ELISA, and
also neutralizes the growth-promoting activity of each. To define the
structure of LSGF and mechanisms by which it exerts its physiological
effects on renal cells in vitro and in vivo, new reagents are required
that will be used to achieve the following specific aims:
1. partially sequence the LSGF protein;
2. use oligonucleotide probes or immunoscreening to clone the gene that
encodes the protein, and study regulation of its expression during cell
growth;
3. develop LSGF immunoassays to study the physiology the protein;
4. determine if LSGF alters nutrient and ion transport in renal epithelial
cells.
Achieving these aims could define the role of this autocrine growth factor
in renal physiology and pathophysiology. Identifying mechanisms by which
the LSGF acts may be an important step towards our long-term goal of
formulating a therapeutic solution containing specific components such as
nutrients and growth factors that could speed regeneration of the kidney
after injury.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Novel Agent with Dual Functions to Treat Head and Neck Cancer
-
批准号:8638361
-
项目类别:
-
资助金额:$20.62万
-
财政年份:2014
-
负责人:FREDERICK Gary TOBACK
-
依托单位:
A Novel Agent with Dual Functions to Treat Head and Neck Cancer
-
批准号:8777091
-
项目类别:
-
资助金额:$17.18万
-
财政年份:2014
-
负责人:FREDERICK Gary TOBACK
-
依托单位:
Targeting Tight Junctions To Treat Mucositis
-
批准号:7817005
-
项目类别:
-
资助金额:$23.4万
-
财政年份:2009
-
负责人:FREDERICK Gary TOBACK
-
依托单位:
Targeting Tight Junctions To Treat Mucositis
-
批准号:7660772
-
项目类别:
-
资助金额:$19.5万
-
财政年份:2009
-
负责人:FREDERICK Gary TOBACK
-
依托单位:
A Novel Cytoprotective Peptide for GI Epithelial Cell
-
批准号:6757728
-
项目类别:
-
资助金额:$15.25万
-
财政年份:2004
-
负责人:FREDERICK Gary TOBACK
-
依托单位:
A Novel Cytoprotective Peptide for GI Epithelial Cell
-
批准号:6881136
-
项目类别:
-
资助金额:$15.25万
-
财政年份:2004
-
负责人:FREDERICK Gary TOBACK
-
依托单位:
BINDING OF CALCIUM CRYSTALS WITH RENAL CELLS
-
批准号:6600908
-
项目类别:
-
资助金额:$10.78万
-
财政年份:2002
-
负责人:FREDERICK Gary TOBACK
-
依托单位:
BINDING OF CALCIUM CRYSTALS WITH RENAL CELLS
-
批准号:6502964
-
项目类别:
-
资助金额:$10.78万
-
财政年份:2001
-
负责人:FREDERICK Gary TOBACK
-
依托单位:
BINDING OF CALCIUM CRYSTALS WITH RENAL CELLS
-
批准号:6349623
-
项目类别:
-
资助金额:$10.78万
-
财政年份:2000
-
负责人:FREDERICK Gary TOBACK
-
依托单位:
NOVEL GROWTH FACTOR RELEASED BY KIDNEY EPITHELIAL CELLS
-
批准号:2141012
-
项目类别:
-
资助金额:$15.37万
-
财政年份:1987
-
负责人:FREDERICK Gary TOBACK
-
依托单位:
NOVEL GROWTH FACTOR RELEASED BY KIDNEY EPITHELIAL CELLS
-
批准号:3239577
-
项目类别:
-
资助金额:$16.61万
-
财政年份:1987
-
负责人:FREDERICK Gary TOBACK
-
依托单位:
NOVEL GROWTH FACTOR RELEASED BY KIDNEY EPITHELIAL CELLS
-
批准号:3239573
-
项目类别:
-
资助金额:$17.32万
-
财政年份:1987
-
负责人:FREDERICK Gary TOBACK
-
依托单位:
NOVEL GROWTH FACTOR RELEASED BY KIDNEY EPITHELIAL CELLS
-
批准号:3239578
-
项目类别:
-
资助金额:$14.82万
-
财政年份:1987
-
负责人:FREDERICK Gary TOBACK
-
依托单位:
NOVEL GROWTH FACTOR RELEASED BY KIDNEY EPITHELIAL CELLS
-
批准号:3239576
-
项目类别:
-
资助金额:$15.37万
-
财政年份:1987
-
负责人:FREDERICK Gary TOBACK
-
依托单位:
MEMBRANES AND PHOSPHOLIPIDS IN RENAL HYPERPLASIA
-
批准号:3236011
-
项目类别:
-
资助金额:$21.45万
-
财政年份:1986
-
负责人:FREDERICK Gary TOBACK
-
依托单位:
MEMBRANES AND PHOSPHOLIPIDS IN RENAL HYPERPLASIA
-
批准号:3236009
-
项目类别:
-
资助金额:$22.01万
-
财政年份:1986
-
负责人:FREDERICK Gary TOBACK
-
依托单位:
MEMBRANES AND PHOSPHOLIPIDS IN RENAL HYPERPLASIA
-
批准号:3236010
-
项目类别:
-
资助金额:$23.51万
-
财政年份:1986
-
负责人:FREDERICK Gary TOBACK
-
依托单位:
MEMBRANES AND PHOSPHOLIPIDS IN RENAL HYPERPLASIA
-
批准号:3236006
-
项目类别:
-
资助金额:$22.87万
-
财政年份:1986
-
负责人:FREDERICK Gary TOBACK
-
依托单位:
MEMBRANES AND PHOSPHOLIPIDS IN RENAL HYPERPLASIA
-
批准号:2140016
-
项目类别:
-
资助金额:$23.71万
-
财政年份:1986
-
负责人:FREDERICK Gary TOBACK
-
依托单位:
MEMBRANES AND PHOSPHOLIPIDS IN RENAL HYPERPLASIA
-
批准号:3236008
-
项目类别:
-
资助金额:$22.95万
-
财政年份:1986
-
负责人:FREDERICK Gary TOBACK
-
依托单位:
海外基金